Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

3.3K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
3.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

Basement Membrane-Related Genes C1QTNF3, PTGER2, CAMK2N1, PRSS36, and B3GNT7: Novel Biomarkers for Coronary Artery Disease.

Cardiovascular therapeutics·2026
Same journal

Salvianolic Acid B Alleviates Atrial Fibrillation-Associated Fibrosis With Modulation of COL1A2 and the PI3K-AKT Pathway.

Cardiovascular therapeutics·2026
Same journal

Joint Association of Cholesterol, High-Density Lipoprotein and Glucose Index, and Circadian Syndrome With Incidence of Cardiovascular Disease: Results From National Longitudinal Prospective Studies.

Cardiovascular therapeutics·2026
Same journal

Comparative Effectiveness and Safety of Interventions for Atrial Fibrillation in Heart Failure: A Network Meta-Analysis of Randomized Trials.

Cardiovascular therapeutics·2026
Same journal

Integrated Network Pharmacology and Experimental Validation Approach to Systematically Elucidate the Cardioprotective Mechanisms of Shengmai Injection.

Cardiovascular therapeutics·2026
Same journal

Prasugrel: Reassessing Its Role in Contemporary Antiplatelet Therapy.

Cardiovascular therapeutics·2026

Related Experiment Video

Updated: Mar 30, 2026

A Model of Acute Lung Injury Following Visceral Ischemia-Reperfusion by Supra-Coeliac Aortic Cross Clamping in Rats
06:50

A Model of Acute Lung Injury Following Visceral Ischemia-Reperfusion by Supra-Coeliac Aortic Cross Clamping in Rats

Published on: August 15, 2025

509

IL6/IL10/TLR4 Govern Immunogenic Cell Death in Aortic Dissection.

Yukui Du1, Dongqing Chang1, Bofeng Yu1

  • 1Department of Cardiac Surgery, Center for Cardiac and Panvascular Medicine, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, Xinjiang, China.

Cardiovascular Therapeutics
|March 28, 2026
PubMed
Summary
This summary is machine-generated.

Programmed cell death (PCD) drives aortic dissection (AD). We identified IL6, IL10, and TLR4 as key biomarkers, revealing immune-vascular crosstalk and potential drug targets for AD therapy.

Keywords:
aortic dissectionbiomarkersimmune infiltrationprogrammed cell deathregulatory networkstherapeutic targetstranscriptome sequencing

More Related Videos

Vasodilation of Isolated Vessels and the Isolation of the Extracellular Matrix of Tight-skin Mice
08:09

Vasodilation of Isolated Vessels and the Isolation of the Extracellular Matrix of Tight-skin Mice

Published on: March 24, 2017

8.7K
Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity
07:09

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity

Published on: January 7, 2019

8.1K

Related Experiment Videos

Last Updated: Mar 30, 2026

A Model of Acute Lung Injury Following Visceral Ischemia-Reperfusion by Supra-Coeliac Aortic Cross Clamping in Rats
06:50

A Model of Acute Lung Injury Following Visceral Ischemia-Reperfusion by Supra-Coeliac Aortic Cross Clamping in Rats

Published on: August 15, 2025

509
Vasodilation of Isolated Vessels and the Isolation of the Extracellular Matrix of Tight-skin Mice
08:09

Vasodilation of Isolated Vessels and the Isolation of the Extracellular Matrix of Tight-skin Mice

Published on: March 24, 2017

8.7K
Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity
07:09

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity

Published on: January 7, 2019

8.1K

Area of Science:

  • Cardiovascular Biology
  • Immunology
  • Molecular Medicine

Background:

  • Aortic dissection (AD) is a critical cardiovascular emergency.
  • Programmed cell death (PCD) is implicated in AD pathogenesis, but mechanisms are unclear.
  • This study identifies PCD-related biomarkers for novel therapeutic strategies.

Purpose of the Study:

  • To systematically investigate programmed cell death (PCD)-related biomarkers in aortic dissection (AD).
  • To identify novel therapeutic targets for AD by analyzing molecular drivers of PCD.

Main Methods:

  • Integrated multiomics analysis of aortic tissues from AD patients and controls.
  • Identified differentially expressed genes (DEmRNAs) and intersected them with programmed cell death-related genes (PCD-RGs).
  • Utilized network analysis, immune infiltration profiling, and drug-target prediction to characterize key drivers.

Main Results:

  • Identified IL6, IL10, and TLR4 as significant PCD-associated biomarkers in AD.
  • Biomarkers are enriched in immunoregulatory pathways, with IL10 correlating strongly with immune cells and endothelial cells.
  • Discovered regulatory networks involving transcription factors and miRNAs, and identified 91 potential repurposable drugs.

Conclusions:

  • IL6, IL10, and TLR4 are central regulators of PCD in AD pathogenesis.
  • Immune-vascular crosstalk and immunogenic cell death are key therapeutic targets for AD.
  • The identified biomarker network and drug candidates offer a framework for precision AD therapies.